1 is a key signal transduction molecule activated by many cell surface receptors. Activation of PLC leads to hydrolysis of phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P 2 ) to generate inositol 1,4,5-trisphosphate (Ins(1,4,5)P 3 ) and 1,2-diacylglycerol (DAG). G protein-coupled receptors (GPCRs), receptor tyrosine kinases, and monomeric G proteins are all capable of activating this pathway via PLC␤ (or the Ca 2ϩ -activated PLC␦), PLC␥ and PLC⑀, respectively (1). Ins(1,4,5)P 3 mediates Ca 2ϩ release from intracellular stores, whereas DAG recruits and activates protein kinase C (PKC) to initiate specific protein phosphorylation cascades. responses because oscillatory Ins(1,4,5)P 3 , DAG, and PKC signals have also been reported (5-9).
Phosphoinositide-specific phospholipase C (PLC) 1 is a key signal transduction molecule activated by many cell surface receptors. Activation of PLC leads to hydrolysis of phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P 2 ) to generate inositol 1,4,5-trisphosphate (Ins(1,4,5)P 3 ) and 1,2-diacylglycerol (DAG). G protein-coupled receptors (GPCRs), receptor tyrosine kinases, and monomeric G proteins are all capable of activating this pathway via PLC␤ (or the Ca 2ϩ -activated PLC␦), PLC␥ and PLC⑀, respectively (1) . Ins(1,4,5)P 3 mediates Ca 2ϩ release from intracellular stores, whereas DAG recruits and activates protein kinase C (PKC) to initiate specific protein phosphorylation cascades. Imaging of cells using Ca 2ϩ -sensitive dyes has revealed complex patterns of response, such as Ca 2ϩ waves, and frequency-encoded Ca 2ϩ oscillations (2) . It is now well established that the versatility of Ca 2ϩ signaling lies in the speed, amplitude, and temporal pattern of rises in intracellular Ca 2ϩ ([Ca 2ϩ ] i ), which are then decoded by intracellular signaling molecules, such as PKC (3) and Ca 2ϩ /calmodulin (Ca 2ϩ /CaM)-dependent protein kinase II (4) . Furthermore, it would now appear that temporal regulation of signaling molecules is not restricted to Ca 2ϩ responses because oscillatory Ins(1,4,5)P 3 , DAG, and PKC signals have also been reported (5) (6) (7) (8) (9) .
Advances in imaging techniques and the advent of green fluorescent protein (GFP)-tagged proteins, or protein domains, have revolutionized the study of intracellular signaling processes. Fluctuations in Ins(1,4,5)P 3 levels within a cell can now be monitored in real time, as first demonstrated by Hirose et al. (10) using the translocation of eGFP-PH PLC␦ (the PH domain of PLC␦1 tagged to eGFP) in Madin-Darby canine kidney cells. Although initial studies used this biosensor to detect changes in plasma membrane PtdIns(4,5)P 2 levels (11, 12) , more recent work indicates that the translocation of eGFP-PH PLC␦ is predominantly, although perhaps not exclusively (13) , controlled by an increase in Ins(1,4,5)P 3 production (6, 7, 10, 14; for review, see Ref. 15) . Similarly, DAG levels can also be monitored in the single cell using the DAG binding domain of PKC␥ (eGFP-C1 2 -PKC␥) (4) , which translocates to the plasma membrane in response to agonist. These fluorescent "biosensors" have revealed oscillatory patterns of Ins(1,4,5)P 3 production in response to ATP in Madin-Darby canine kidney cells (10) , type 5a metabotropic glutamate (mGlu5a) receptor activation in Chinese hamster ovary (CHO) and human embryonic kidney cells (6, 7, 16) , and ␣ 1B -adrenergic receptor stimulation in CHO cells (8) .
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Ins(1,4,5)P 3 , inositol 1,4,5-trisphosphate; KHB, Krebs-Henseleit buffer; mACh, muscarinic acetylcholine; MARCKS, myristoylated alanine-rich C kinase substrate; MCh, methacholine; mGlu5a, type 5a metabotropic glutamate; NA, noradrenaline; PKC, protein kinase C; PLD, phospholipase D; PtdIns(4,5)P 2 , phosphatidylinositol 4,5-bisphosphate. ger production. Although both mGlu5a and ␣ 1B -adrenergic receptors couple to G␣ q/11 and initiate synchronous Ins(1,4,5)P 3 and Ca 2ϩ oscillations (7, 8) , the contribution of Ins(1,4,5)P 3 to the resultant Ca 2ϩ response differs between these receptors. Thus, mGlu5a receptor-mediated Ca 2ϩ oscillations are maintained by a PKC-mediated feedback inhibition of receptor signaling, which gives rise to the Ins(1,4,5)P 3 oscillations (7). In contrast, ␣ 1B -adrenergic receptor-mediated Ins(1,4,5)P 3 oscillations result from a positive feedback effect of oscillatory Ca 2ϩ onto activated PLC (8) . mGlu5a receptor-mediated oscillations in DAG levels have also been reported in astrocytes (5) . Using a total internal reflection fluorescence approach, eGFP-C1 2 -PKC␥ and a more DAG-sensitive probe, GFP-C1 2 -PKC␦, were shown to oscillate to and from the plasma membrane in response to glutamate addition, reflecting fluctuations in DAG levels. These data, and the findings of Nash et al. (7) , strongly suggest that the oscillatory DAG responses are responsible for a PKC-mediated negative feedback on the mGlu5a receptor/ G␣ q/11 /PLC pathway.
In this study we have assessed for the first time in single intact cells the relationship among Ins(1,4,5)P 3 , DAG, Ca 2ϩ , and PKC. A CHO cell model stably expressing both the M 3 muscarinic acetylcholine (mACh) and the ␣ 1B -adrenergic receptor (CHO-m3/␣ 1B ) has been employed. Both of these receptor types couple via G␣ q/11 to PLC␤, although the M 3 mACh receptor is a more efficacious stimulator of PLC activity than the ␣ 1B -adrenergic receptor (8) . This model has allowed the analysis of GPCR-mediated PLC activity and more specifically, single cell estimates of relative receptor reserves for the different signal pathway intermediates studied (referred to here as "signaling reserve" as relative levels of Ins(1,4,5)P 3 , Ca 2ϩ , DAG, and PKC activity are compared). Furthermore, the oscillatory pattern of signaling observed with threshold stimulation of the ␣ 1B -adrenergic receptor (8) provides a model to study the synchrony of Ins(1,4,5)P 3 and DAG production with Ca 2ϩ in single cells. These have then been compared with temporal patterns of PKC recruitment using conventional (PKC␤II) and novel (PKC⑀) PKC isoenzymes and to PKC activation using the substrate eGFP-MARCKS. We report here on the presence of oscillatory messenger production and determine the contribution of Ca 2ϩ mobilization and entry on the recruitment and activation of PKC isoenzymes.
EXPERIMENTAL PROCEDURES
Cell Culture-CHO cells stably expressing human M 3 muscarinic receptors (3.4 pmol mg Ϫ1 protein) and human ␣ 1B -adrenergic receptors (2.3 pmol mg Ϫ1 protein) (CHO-m3/␣ 1B cells) were maintained in minimal essential medium-␣ supplemented with 10% fetal calf serum, 50 units ml Ϫ1 penicillin, 50 g ml Ϫ1 streptomycin, 2.5 g ml Ϫ1 amphotericin B (Invitrogen), 400 g ml Ϫ1 Geneticin (G418), and 350 units ml (95/5); 3 ϫ 1-ml washes) and incubated for 20 min in 1 ml of KHB at 37°C. LiCl (final concentration 10 mM) was added to each well for a further 10 min. Cells were then treated with drugs and incubated for 15 min. Reactions were terminated by the addition of 500 l of ice-cold 0.5 M trichloroacetic acid. Samples were neutralized and the [ 3 H]InsP x fraction recovered by Dowex anion exchange chromatography column and quantified using liquid scintillation counting (17) .
Ins(1,4,5)P 3 Mass Assay-CHO-m3/␣ 1B cells were seeded in 24-well multidishes and incubated overnight, before being washed incubated in KHB for 30 min at 37°C. Cells were treated with either 10 M MCh or 10 M NA for the times indicated and the reaction terminated by addition of ice-cold 0.5 M trichloroacetic acid. Sample neutralization and Ins(1,4,5)P 3 mass determination was carried out as described previously (18) .
Phospholipase D (PLD) Activity Assay-PLD activity was assessed using the method described by Purkiss and Boarder (19) . Cells grown to ϳ90% confluence in 24-well multidishes were transferred to phosphatefree minimal essential medium (Sigma) and incubated for 30 min before the addition of 33 P i (2 Ci well Ϫ1 ; Amersham Biosciences) then incubated for a further 24 h. Cells were washed with KHB (3 ϫ 1 ml) to remove free radiolabel and then incubated for 10 min in the presence or absence of butan-1-ol (or where indicated, butan-2-ol). Cells were then treated with either 100 M MCh or 100 M NA for the indicated times. Incubations were terminated by the addition of 500 l of ice-cold 1 M trichloroacetic acid. After 15 min the lipid fraction was extracted with 1 ml of chloroform/methanol/concentrated HCl (40:80:1, v/v/v) and phase resolution by the addition of 300 l of chloroform and 500 l of 0.1 M HCl. Samples were centrifuged (3,500 ϫ g, 5 min, 4°C) and a known volume of the lower, organic phase recovered and evaporated to dryness. Lipid samples were resuspended in 50 l of chloroform/methanol (95:5, v/v) spotted onto thin layer chromatography plates (Whatman LK6D silica gel plates). Plates were run using a solvent containing ethyl acetate, 2,2,4-trimethylpentane, and glacial acetic acid (9:5:2, v/v/v). 33 P]phosphatidic acid bands were visualized by exposure to film (48 h), and the corresponding bands were then excised and quantified using liquid scintillation counting.
Single Cell Imaging of Ins (1, 4, 5 )P 3 , DAG, MARCKS, and PKC-Cells were seeded onto 25-mm borosilicate coverslips (BDH, UK) and transiently transfected with the appropriate cDNA (1 g well Ϫ1 ) using Genejuice (Novagen) according to the manufacturer's instructions. After 48 h, coverslips were mounted on the stage of an Olympus FV500 microscope, maintained at 37°C with a Peltier unit, and perfused with KHB (5 ml min Ϫ1 ). Visualization of changes in cytosolic fluorescence, in real time, was performed as described previously (8) . Images were captured by excitation at 488 nm using an Olympus FV500 confocal microscope with an oil immersion (ϫ60) objective. Drugs were applied through a perfusion line for the indicated times (generally 2-5 min), resulting in a lag before cell stimulation. Results are expressed as a F 488 self-ratio ((F/F 0 ratio) Ϫ 1), where F is the fluorescence emission at a given time and F 0 is the initial fluorescence. For the DAG sensor, to enable the change in cytosolic fluorescence to be expressed as a numerical increase, data are expressed as 1 Ϫ F 488 self-ratio (1 Ϫ (F/F 0 ) ratio), except for representative traces showing F 488 self-ratio (F/F 0 ). For experiments involving the coimaging of eGFP-tagged constructs with [Ca 2ϩ ] i , cells were loaded with 5 M Fura Red/AM (Molecular Probes) for 60 min at room temperature. eGFP and Fura Red were excited simultaneously using the 488 nm laser line, and Fura Red emissions were collected above 660 nm.
Single Cell Ca 2ϩ Imaging-Cells were grown to 70% confluence on 25-mm coverslips and loaded with 2 M fura-2/AM (Molecular Probes) in KHB for 60 min at room temperature. Cells were then mounted on the stage of a Nikon Diaphot inverted epifluorescence microscope and perfused at 37°C with KHB. Cells were excited at 340 and 380 nm using a Spectramaster II monochromater and sequential images above 510 nm collected with a cooled CCD camera (PerkinElmer Life Sciences). The intracellular Ca 2ϩ signal is expressed as the 340/380 nm ratio, relative to basal levels within each individual cell.
Data Analysis-Graphs and curve fitting of concentration-dependent data were plotted using Prism 3.0 (GraphPad Software, Inc., San Diego) and half-maximal (EC 50 ) values determined using the nonlinear regression analysis available in the software. Data are presented throughout as the mean Ϯ S.E. from at least three separate experiments or as a representative trace of a least three separate experiments. Statistical differences between data sets were determined by one-way analysis of variance for multiple comparisons, followed by Bonferroni's multiple range test at p Ͻ 0.05 (using Prism 3.0 software) or Student's t test (paired or unpaired; p Ͻ 0.05 being considered significant). (1, 4, 5) (Fig. 1A) . Assessment of agonist-stimulated Ins(1,4,5)P 3 levels in cell populations revealed more marked differences between the two receptor populations. 10 M MCh stimulated a biphasic elevation of Ins(1,4,5)P 3 with an initial peak of 526 Ϯ 43 pmol mg Ϫ1 protein at 15 s which decreased to a sustained plateau phase of 250 Ϯ 13.5 pmol mg Ϫ1 protein after 1 min of agonist treatment (Fig. 1B) . In contrast, activation of ␣ 1B -adrenergic receptors (10 M NA) caused only a modest increase in Ins(1,4,5)P 3 with a peak of 71.5 Ϯ 3.1 at 15 s and a plateau of 67.3 Ϯ 7.7 pmol mg Ϫ1 protein after 1 min. Basal levels of Ins(1,4,5)P 3 were 51.3 Ϯ 3.1 pmol mg Ϫ1 protein (Fig. 1B) . The development of the fluorescent probe eGFP-PH PLC␦ has allowed changes in Ins(1,4,5)P 3 levels to be visualized in single cells in real time (15) . Under basal conditions eGFP-PH PLC␦ is located at the plasma membrane because of its affinity for PtdIns(4,5)P 2 ; however, upon PLC activation the biosensor translocates to the cytoplasm because of its 20-fold higher affinity for Ins(1,4,5)P 3 (see Fig. 1C , inset, right panel). Increases in Ins(1,4,5)P 3 can be expressed as the increase in cytoplasmic eGFP-PH PLC␦ fluorescence relative to basal (8) . Peak-and-plateau increases in Ins(1,4,5)P 3 , comparable with cell population measurements, were observed to both agonists ( Table I ). The predominant Ca 2ϩ signal to MCh was an initial peak followed by a maintained plateau response. Only at a low agonist con- Single Cell Assessment of DAG Accumulation-Measurements of DAG production in single cells were made using the eGFP-C1 2 -PKC␥ construct first developed by Oancea and Meyer (4) . This construct contains a tandem repeat of the C1-DAG binding domain of PKC␥ and has been shown to translocate from the cytoplasm to the plasma membrane in a DAGdependent manner. Prior to stimulation eGFP-C1 2 -PKC␥ fluorescence was seen in both the cytoplasmic and nuclear compartments (Fig. 3A inset, left panel) ; stimulation of CHOm3/␣ 1B cells with either MCh or NA produced a biphasic increase in DAG production, indicated by a decrease in cytoplasmic fluorescence, but no detectable change in the nuclear fluorescence (Fig. 3A) . Stimulation with a maximally effective concentration of MCh produced a peak change in cytosolic fluorescence which was twice that caused by maximal NA (Table I) . EC 50 values for MCh and NA were closely comparable with those obtained for the Ins(1,4,5)P 3 response using the eGFP-PH PLC␦ biosensor (see Table I ).
RESULTS

Comparison of Single Cell Ins
Contribution of PLD Activity to M 3 mACh and ␣ 1B -Adrenergic Receptor-mediated DAG Accumulation-It is possible for DAG to be generated via metabolic pathways independently of PLC activity. For example, receptor-stimulated PLD activity results in the hydrolysis of phosphatidylcholine to generate phosphatidic acid that can be metabolized further by phosphatidate phosphohydrolase to DAG (20) . Both M 3 mACh and ␣ 1B -adrenergic receptors have previously been shown to activate PLD (21, 22) . Therefore, to determine whether MCh or NA stimulates PLD activity in CHO-m3/␣ 1B cells, populations of cells labeled with 33 P i were stimulated in the absence or presence of butan-1-ol. This primary alcohol can substitute for water in a PLD-mediated transphosphatidylation reaction, resulting in the accumulation of metabolically stable phosphatidylbutanol (20) . Stimulation of CHO-m3/␣ 1B cells with 100 M MCh or 100 M NA in the presence of 30 mM butan-1-ol resulted in time-dependent, linear increases in [
33 P]phosphatidylbutanol (Fig. 4A ). In the presence of 30 mM butan-2-ol, a secondary alcohol that cannot substitute in the above reaction, no measurable increase in [ 33 P]phosphatidylbutanol accumulation was observed (Fig. 4B) .
Butan-1-ol or butan-2-ol pretreatments (30 mM; 10 min) were used to assess the effect of PLD inhibition on agonist-stimulated changes in DAG in single CHO-m3/␣ 1B cells. No effect of inhibiting PLD activity was observed for either MCh or NA peak or plateau levels of DAG (for data from 1 M MCh stimulation, p Ͼ 0.05, see Fig. 4C ), suggesting a lack of a PLDderived contribution to the DAG response, at least over the initial time course assessed in these imaging experiments.
M 3 mACh and ␣ 1B -Adrenergic Receptor-stimulated PKC Activity Determined by Translocation of MARCKS Protein-MARCKS protein is tethered to the plasma membrane by two conserved regions, an N-terminal myristoylated region and a highly basic effector domain (23) . Phosphorylation of MARCKS by PKC at the effector domain site weakens the electrostatic interaction with the lipid membrane, resulting in a translocation of MARCKS to the cytoplasm (23) . Stimulation of CHOm3/␣ 1B cells, transfected to express eGFP-MARCKS, with MCh or NA caused concentration-dependent eGFP-MARCKS translocation (Fig. 5A) . Consistent with the observed responses for Ins(1,4,5)P 3 and DAG biosensors, eGFP-MARCKS translocation reached an early peak that declined to a lower plateau level that was maintained until the agonist perfusion was terminated (Fig. 5A) . Interestingly, the translocated protein appeared to be distributed heterogeneously in the cytoplasm, with a concentration in the perinuclear region similar to that observed previously in INS-1 (24) and human embryonic kidney (9) cells. Both agonists induced concentration-dependent translocations of the MARCKS with similar maximal responses being achieved for MCh and NA (peak responses, 3.38 Ϯ 0.13 and 3.10 Ϯ 0.13 F/F 0 , respectively, p Ͼ 0.05; Fig. 5B ). Comparison of EC 50 values (Table I ) indicated a consistent 9-fold difference in response for DAG production and PKC activation, for each receptor.
MARCKS protein translocation to the cytoplasm is not only regulated by PKC activity because cytoplasmic Ca 2ϩ concentrations can also exert effects through Ca 2ϩ /CaM binding to MARCKS (20) . The relative contributions of PKC and Ca 2ϩ / CaM were examined in CHO-m3/␣ 1B cells. Down-regulation of (Fig. 6A ). In contrast, no effect on agonistinduced eGFP-MARCKS translocation was observed after pretreatment of the cells with the Ca 2ϩ /CaM inhibitor W7 (25 M, 15 min pretreatment) (Fig. 6B) . These data are consistent with a previous study in which oscillatory MARCKS translocation (in response to mGlu5 receptor activation) was inhibited by the PKC inhibitor Gö6976 (9) .
Relationship between MCh-and NA-mediated Single Cell Second Messenger Production in CHO-m3/␣ 1B Cells-Compar-
ison of M 3 mACh and ␣ 1B -adrenergic receptor-mediated second messenger responses in single cells revealed substantially greater maximal peak responses (R max ) to MCh than to NA, indicating that for the immediate products of PLC activity, stimulation of the M 3 mACh receptor produces the more robust response. The calculated EC 50 values (see Fig. 7 and Table I) for each receptor type demonstrated that measured Ins(1,4,5)P 3 and DAG responses were stimulated with similar potencies. Comparison of EC 50 values for Ins(1,4,5)P 3 production and resultant Ca 2ϩ mobilization revealed 5-and 13-fold differences for the respective responses to MCh and NA ( Fig. 7 and Table I ), whereas both agonists produced a 9-fold difference in responses between DAG production and MARCKS protein translocation. As would be anticipated for downstream responses possessing a greater signaling reserve, differences in R max values between M 3 mACh and ␣ 1B -adrenergic receptormediated responses were less marked with respect to the downstream signaling elements (see Table I ). vided agonist potency estimates similar to those measured in population studies and allowed the comparison of EC 50 values with respect to different downstream signaling intermediates within individual cells. A further major advantage of this imaging method is that it also allows signaling events to be followed with a high degree of temporal resolution. In this way oscillatory Ins(1,4,5)P 3 responses to agonist stimulation have already been identified in a number of cell types (6, 8, 10) . Using a stimulation protocol of stepwise increases in low concentrations of NA, we have examined the effects of increasing ␣ 1B -adrenergic receptor stimulation, by NA, on the temporal profiles of Ins(1,4,5)P 3 and DAG, while simultaneously measuring [Ca 2ϩ ] i (using the Ca 2ϩ -sensitive dye Fura Red) in the same cell. Low concentrations of NA (stepwise increases through 0.01, 0.03, and 0.1 M) produced oscillatory Ca 2ϩ responses in the majority of cells examined (Fig. 8A) . However, at the minimum concentration of NA (0.01 M) required to mediate a Ca 2ϩ response, increases in Ins(1,4,5)P 3 were often not detected (7 of 17 cells, n ϭ 3) or were nonoscillatory (8 of 17 cells) (for representative trace, see Fig. 8A ). This pattern of response at a threshold concentration of agonist is consistent with oscillatory Ca 2ϩ responses arising through an intrinsic property of the Ins(1,4,5)P 3 receptor to respond to a small increase in Ins(1,4,5)P 3 (25) . Similarly, oscillations in [Ca 2ϩ ] i could sometimes be detected without any measurable changes in DAG production. Thus, when stimulated with 0.01 M NA, Ca 2ϩ was observed to oscillate in 9 of 14 cells analyzed, whereas oscillations in DAG levels were only present in 2 (of 14) cells. At higher agonist concentrations (0.1 M NA, Fig. 8A ) oscillatory patterns of Ins(1,4,5)P 3 and DAG (average frequency, 4.4 Ϯ 0.3 (13 cells) and 3.7 Ϯ 0.5 (6 cells) oscillations min Ϫ1 , respectively) could be observed. Importantly, these oscillations in second messenger production occurred synchronously with oscillations in [Ca 2ϩ ] i . As outlined above, recruitment of PKCs to the plasma membrane may involve DAG and/or Ca 2ϩ depending on the PKC isoenzyme. In CHO-m3/␣ 1B cells transfected with the conventional PKC isoform PKC␤II (which contains both Ca 2ϩ and DAG binding domains), oscillatory recruitment of the kinase was observed which was synchronous with the Ca 2ϩ response (5.6 Ϯ 0.3 oscillations min (Fig. 8B) . Indeed, our data indicate that PKC␤II is more sensitive than PKC⑀ to threshold concentrations of NA (peak F/F 0 response at 0.01 M NA: PKC␤II, 0.47 Ϯ 0.04 (28 cells), PKC⑀, 0.17 Ϯ 0.02 (24 cells) p Ͻ 0.05). Thus, Ca 2ϩ may control PKC translocation to the membrane at two distinct levels, either via a direct effect on conventional PKCs or via a positive feedback on PLC thereby mediating DAG oscillations and hence oscillatory recruitment of novel PKCs. To determine the activity of the PKC isoenzymes a similar stepwise NA stimulation protocol was employed to monitor eGFP-MARCKS translocation (again measured simultaneously with Ca 2ϩ ). Similar to effects on Ins(1,4,5)P 3 and DAG generation, threshold concentrations of NA (0.01 M) caused an oscillatory Ca 2ϩ response in the absence of eGFP-MARCKS translocation (18 of 23 cells; for a representative trace, see Fig. 9 ). However, an incremental increase in the NA concentration (to 0.03 M) caused synchronous MARCKS and Ca 2ϩ responses (17 of 23 cells produced synchronous oscillations, 6 out 23 produced peak-and-plateau responses). Thus, increases in [Ca 2ϩ ] i alone were not capable of activating PKC activity.
Temporal Profiles of Single Cell Second Messenger Generation in CHO-
Role of Ca 2ϩ Mobilization and Entry in Single Cell
Second Messenger Production-Clearly from the above data, low levels of ␣ 1B -adrenergic receptor stimulation result in an oscillatory activation of PLC. Previous work suggests that oscillatory patterns of Ins(1,4,5)P 3 generation result from a positive feedback effect of Ca 2ϩ on agonist-stimulated PLC activity (8) . However, there is also the possibility of a direct effect of Ca 2ϩ on basal PLC activity (or indeed the fluorescent biosensors themselves). For example, an interaction of Ca 2ϩ with the C2 domain of conventional PKC isoenzymes causes recruitment to the plasma membrane (4). To examine this possibility further, Fura Red-loaded CHO-m3/␣ 1B cells were treated with the sarco/endoplasmic reticulum Ca 2ϩ ATPase pump inhibitor cyclopiazonic acid (CPA, 10 M for 5 min) in the absence of extracellular Ca 2ϩ first to mobilize Ca 2ϩ from intracellular stores and then perfused with normal KHB (containing 1.3 mM Ca 2ϩ ), in the continued presence of CPA, to initiate the Ca 2ϩ entry pathway. In this way, the effects of Ca 2ϩ release, and Ca 2ϩ entry, on each biosensor could be examined independently. Visualization of responses to Ins(1,4,5)P 3 and DAG indicated that these biosensors were insensitive to changes in [Ca 2ϩ ] i (see Fig. 10 ). Upon CPA-mediated Ca 2ϩ release an F/F 0 increase of 0.05 Ϯ 0.01 for Ins(1,4,5)P 3 and 0.02 Ϯ 0.01 for DAG were observed (32 and 15 cells, respectively) . Furthermore, Ca 2ϩ entry (on extracellular Ca 2ϩ readdition) resulted in only 0.08 Ϯ 0.02 and 0.04 Ϯ 0.02 F/F 0 increases for Ins(1,4,5)P 3 and DAG biosensors, respectively. Thus, in the absence of receptor activation, PLC activity does not appear to be sensitive to increases in [Ca 2ϩ ] i . Similarly, PKC⑀ did not translocate in response to either Ca 2ϩ release (F/F 0 increase 0.04 Ϯ 0.02) or Ca 2ϩ entry (F/F 0 increase 0.06 Ϯ 0.01) (14 cells, n ϭ 3; for representative trace, see Fig. 10, top) . In contrast, the conventional PKC isoenzyme, PKC␤II, was recruited to the plasma membrane transiently in response to Ca 2ϩ mobilization (F/F 0 increase 1.20 Ϯ 0.01) and more robustly in response to Ca 
DISCUSSION
A fundamental question in signal transduction research is how extracellular stimuli, acting via specific cell surface receptors, can generate receptor-(and perhaps agonist)-specific sets of changes in the intracellular milieu (27) (28) (29) . For example, it is often observed that GPCRs that apparently couple to common subpopulations of G proteins can elicit quite distinct signaling outcomes. One answer lies in the ability of different activated receptors to cause different spatial and temporal patterns of second messenger response. Thus, it has been known for some time that intracellular Ca 2ϩ signals can be localized spatially within a cell and/or can manifest as a series of repetitive oscillations, the frequency of which is regulated by cell surface receptor stimulus-strength intensity (2, 27) . However, whether second messenger systems linked to GPCR activation can also encode similar information in signaling networks has yet to be explored thoroughly. This issue has now begun to be addressed by the use of eGFP-tagged constructs encoding either functional full-length proteins (such as PKC) or polypeptides that encode only a second messenger binding domain (see 15, 30, 31) . This approach has been particularly successful for visualizing the downstream signaling events that follow the activation of GPCRs coupled to the PLC pathway. Thus, detailed analyses are emerging concerning the temporal encoding of Ins(1,4,5)P 3 ( There is a concern that biosensor expression may perturb the cellular events they are designed to report (12, 13). However, preliminary experiments showed that single cell Ins(1,4,5)P 3 changes measured using eGFP-PH PLC␦ yielded EC 50 values similar to biochemical measurements of phosphoinositide turnover in populations of cells (Table I) . Although these data suggest that biosensor expression per se does not appreciably affect the changes in signaling intermediates they report, we cannot exclude the possibility that biosensors may "buffer" changes in signaling intermediates, especially at low stimulus strengths.
Initial work demonstrated that activation of M 3 mACh and ␣ 1B -adrenergic receptors resulted in different magnitudes of increase in Ins(1,4,5)P 3 and DAG accumulation; however, it was evident that changes in these second messengers stimulated by each receptor closely paralleled each other. This congruency indicates that at least within the time frames studied here it is highly likely that both Ins(1,4,5)P 3 and DAG are derived wholly or substantially from the hydrolysis of PI(4,5)P 2 by PLC and that the rates of elimination of these messengers (by inositol trisphosphate-5-phosphatase and/or inositol trisphosphate 3-kinase, and DAG kinase and/or DAG lipase for Ins(1,4,5)P 3 and DAG, respectively) is also likely to be closely matched. Thus, although MCh and NA each caused a modest activation of PLD activity in these cells, exposure of cells to butan-1-ol had no effect on agonist-stimulated DAG accumulation. Similar conclusions have been reached in another single cell imaging study investigating DAG accumulation/PKC regulation in human embryonic kidney cells stably expressing the mGlu5a receptor (9), but previous work in cell populations has emphasized that multiple pathways can give rise to DAG (22, 35) leading to discrepant Ins(1,4,5)P 3 and DAG profiles.
The congruency of the Ins(1,4,5)P 3 and DAG responses in our cells meant that meaningful comparisons at the level of downstream signaling components could also be readily made at the single cell level. The increased signaling reserve for the response downstream of second messenger accumulation was evident for both agonist-stimulated increases in [Ca 2ϩ ] i and the translocation of MARCKS protein, which has been validated in this study and previously as an index of PKC activity (9, 24, 36, 37) . This increase in signaling reserve was also evident in that the maximal responses elicited by NA now approached those stimulated by MCh and by the approximately 10-fold leftward shifts in the concentration-response curves for Ca 2ϩ /MARCKS relative to those for Ins(1,4,5)P 3 /DAG (see Fig. 7 ). This relationship delineated in single cells advances previous work conducted in cell populations that have estimated the extent of the signal augmentation between Ins(1,4,5)P 3 and Ca 2ϩ (38, 39 Guided by these data, we next investigated how receptor activation, and hence stimulus strength intensity, affects the temporal profile of second messenger accumulation in single cells. The less efficacious ␣ 1B -adrenergic receptor was the focus of this aspect of the study because submaximal levels of receptor activation cause complex signaling network behaviors. Thus, in a previous study we showed that low concentrations of NA can produce oscillatory Ins(1,4,5)P 3 and Ca 2ϩ responses in this cell line, with Ins(1,4,5)P 3 oscillations occurring at higher stimulus strengths than are required to elicit Ca 2ϩ oscillations (8) . This suggests that an oscillatory PLC activity requires G␣ q/11 activation in addition to positive Ca 2ϩ feedback. Significantly, we now show that oscillatory DAG responses are also observed within the same agonist concentration range as those required to cause a similar pattern of Ins(1,4,5)P 3 response. It is well established that the frequency of intracellular Ca 2ϩ oscillations is often (although not invariably; see Ref. 7) enhanced by increasing concentrations of agonists that stimulate PLC-coupled receptors (27) . Because of the positive feedback effect of Ca 2ϩ on PLC activity (8) , it would appear that the frequency of Ins(1,4,5)P 3 and DAG oscillations can similarly be controlled. The data presented here also demonstrate that the frequency encoding of second messenger responses is faithfully transduced to downstream signaling elements. Thus, oscillatory recruitment of both conventional (PKC␤II) and novel (PKC⑀) isoenzymes of PKC was observed. In the case of PKC␤II, it is likely that this is principally because of the C2 Ca 2ϩ binding domain (4) . In contrast, the lack of this C2 domain in PKC⑀ suggests that this isoenzyme responds directly to oscillations in DAG concentration. Thus, for both the conventional and novel PKC isoenzymes examined here Ca 2ϩ is instrumental in the translocation process, either by binding directly to the conventional PKCs or indirectly by acting on PLC to generate an oscillatory DAG response activating the novel PKCs. Furthermore, the single cell eGFP-MARCKS data strongly suggest that Ca 2ϩ -dependent recruitment of PKC␤II alone is insufficient to stimulate enzymic activity (see Fig. 9 ).
In the present study, single cell biosensors of PLC activity have been used to demonstrate the importance of Ca 2ϩ to initiate and synchronize frequency-encoded second messenger signals for the ␣ 1B -adrenergic receptor. Although oscillatory PKC activity can occur in response to a maintained level of DAG in the presence of Ca 2ϩ oscillations (4), our work suggests a more integrated system in which Ca 2ϩ , via a positive feedback effect on PLC, also produces synchronous oscillations in DAG. This model suggests that the primary source of oscillations must be the InsP 3 receptor responsible for Ca 2ϩ mobilization. This regenerative form of Ca 2ϩ -induced Ca 2ϩ -release (CICR) is an integral property of the InsP 3 receptor (40) . By regulating multiple levels of PLC-linked signal transduction pathways, Ca 2ϩ is able to maintain frequency encoding of the signal to downstream elements, such as cellular targets for PKC phosphorylation. Thus, the intrinsic property of the InsP 3 receptor to codetect changes in Ins(1,4,5)P 3 and Ca 2ϩ and control their levels via Ca 2ϩ feedback onto PLC enables the cell to produce frequency-encoded downstream second messenger responses dependent upon the agonist binding and the efficacy of the activated GPCR.
